D-0249-2025 Class II Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0249-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Feb 6, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 9840 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 12, 2025
Initiation Date
Feb 6, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9840 bottles

Product description

Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide within in the USA.

Code information

Lot #: AD16615, Exp. Date 07/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0249-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0249-2025. Report a data issue: hello@regdatalab.com.